Ohcanbohtosat - Yoko Hamada
- Čájehuvvo 1 - 5 / 5
-
1
-
2
Chemoattractants for neutrophils in lipopolysaccharide‐induced inflammatory exudate from rats are not interleukin‐8 counterparts but gro‐gene‐product/melanoma‐growth‐stimulating‐ac... Dahkki Kazuyoshi Watanabe, Megumi Iida, Kiyosumi Takaishi, Tadaaki SUZUKI, Yoko Hamada, Yoshio Iizuka, Susumu Tsurufuji
Almmustuhtton 1993Artigo -
3
HDL/Apolipoprotein A-I Binds to Macrophage-Derived Progranulin and Suppresses its Conversion into Proinflammatory Granulins Dahkki Hanayuki Okura, Shizuya Yamashita, Tohru Ohama, Ayami Saga, Aya Yamamoto-Kakuta, Yoko Hamada, Nagako Sougawa, Reiko Ohyama, Yoshiki Sawa, Akifumi Matsuyama
Almmustuhtton 2010Artigo -
4
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations Dahkki Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, Kentaro Yamazaki, Akihito Tsuji, Takashi Ura, Axel Grothey, Eric Van Cutsem, Thierry André, Frank Cihon, Yoko Hamada, Atsushi Ohtsu
Almmustuhtton 2014Artigo -
5
Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting Dahkki Kensei Yamaguchi, Yoshito Komatsu, Taroh Satoh, Hiroyuki Uetake, Takayuki Yoshino, Toshirou Nishida, Naoya Yamazaki, Hajime Takikawa, Takashi Morimoto, Masayuki Chosa, Toshiyuki Sunaya, Yoko Hamada, Kei Muro, Kenichi Sugihara
Almmustuhtton 2019Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Chemistry
Internal medicine
Adverse effect
Biochemistry
Biology
Cancer
Colorectal cancer
Molecular biology
Receptor
Regorafenib
Alternative medicine
Apolipoprotein B
Aqueous solution
Beta-Cyclodextrins
Botany
Cell biology
Cell culture
Chemotaxis
Cholesterol
Clinical endpoint
Clinical trial
Confidence interval
Cyclodextrin
Cytokine
Dissolution
Drug
Endocrinology
Enzyme
Exudate